Implementation of a population-based epidemiological rare disease registry: Study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Nagel, Gabriele ^a   Ünal, Hatice ^a   Rosenbohm, Angela ^a   Ludolph, Albert C ^a   Rothenbacher, Dietrich ^a   Arnold, G ^b   Adam, T ^c   Neusch, C ^c   Bazner H ^d   Bortlein A ^d   Baier, H ^e   Behne, F ^e   Raape, J ^e   Rothmeier, J ^e   Beattie, J ^f   Peters, J ^f   Kaspar, A ^f   Bengel, D ^g   Bluthardt, M ^h   Schabet, M ^h   Dettmers, C ⁱ   Eppinger, B ^j   Gold, H J ^j   Hecht, M ^k   Heimbach, B ^l   Hendrich, C ^m   Huber, R ^m   Herting, B ⁿ   Schaff Vogelsang M ⁿ   Hulser P J ^c   Patzner, M ^c   Reeh, A ⁿ   Kaendler, S ⁿ   Kimmig, H ^o   Will, H G ^o   Klotzsch C ^p   Kuhne J ^p   Lewis, D ^q   Lindner, A ^q   Lichy, C ^r   Lorenzl, S ^s   Lutz Schuhbauer, S ⁿ   Sabolek, M ⁿ   Maurer M ^t   Schweigert, B ^t   Meinck, H M ^u   Meudt, O ^r   Stroick, M ^r   Muller vom Hagen J ^v   Schols L ^v   Nagele A ^w   Sommer, N ^w   Naumann, M ^x   Ratzka, P ^x   Neher, K D ^y   Neuhaus, O ^z   Niehaus, L ⁿ   Trottenberg, T ⁿ   Poerschke, Y ^aa   Weber, F ^aa   Rettenmayr, C ^ab   Sperber, W ^ab   Wessig, C ^ac   Winkler, A ^ad   more..

^a UNIVERSITY OF ULM   (Germany)

^b Abteilung Neurologie   (Germany)

^c Praxis EMSA Singen ^*  (Germany)

^d Klinikum Stuttgart Burgerhospital   (Germany)

^e Abteilung Epileptologie   (Germany)

^f Ostalb Klinikum Aalen   (Germany)

^g Oberschwabenklinik GmbH Ravensburg   (Germany)

^h Abteilung Neurologie   (Germany)

ⁱ Schmieder Kliniken Konstanz   (Germany)

^j Klinikum am Gesundbrunnen   (Germany)

^k Bezirkskrankenhaus Kaufbeuren   (Germany)

^l UNIVERSITY OF FREIBURG   (Germany)

^m Klinikum Friedrichshafen   (Germany)

ⁿ Abteilung Neurologie   (Germany)

^o Kliniken Schwenningen   (Germany)

^p Schmieder Kliniken Allensbach   (Germany)

^q MARIENHOSPITAL STUTTGART   (Germany)

^r Klinikum Memmingen   (Germany)

^s UNIVERSITY OF MUNICH   (Germany)

^t CARITAS KRANKENHAUS   (Germany)

^u UNIVERSITY OF HEIDELBERG   (Germany)

^v UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^w Christophsbad Goppingen   (Germany)

^x KLINIKUM AUGSBURG   (Germany)

^y Vinzenz von Paul Hospital   (Germany)

^z Kliniken Landkreis Sigmaringen GmbH   (Germany)

^aa BUNDESWEHRKRANKENHAUS ULM   (Germany)

^ab KLINIKUM ESSLINGEN   (Germany)

^ac UNIVERSITY OF WÜRZBURG   (Germany)

^ad TECHNICAL UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

Amyotrophic lateral sclerosis; Registry; Risk factors

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD SAMPLING; CLINICAL PROTOCOL; DISEASE REGISTRY; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; COMMUNITY HEALTH PLANNING; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INFORMATION SYSTEMS; MALE; RARE DISEASES; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84873730775     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-22     Document Type: Article

References (30)

1. Gliklich RE, Dreyer N. Registries for Evaluating Patient Outcomes: A User's Guide [Internet] 2010, [cited 2011 May 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK49444/.
2. Weddell JM. Registers and registries: a review. Int J Epidemiol 1973, 2(3):221-228. 10.1093/ije/2.3.221, 4359831.
3. Drolet BC, Johnson KB. Categorizing the world of registries. J Biomed Inform 2008, 41(6):1009-1020. 10.1016/j.jbi.2008.01.009, 18329960.
4. Mathis-Edenhofer S, Piso B. Types of medical registries - definitions, methodological aspects and quality of the scientific work with registries. Wien Med Wochenschr 2011, 161(23-24):580-590.
5. Schieppati A, Henter J-I, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet 2008, 371(9629):2039-2041. 10.1016/S0140-6736(08)60872-7, 18555915.
6. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet 2011, 377(9769):942-955. 10.1016/S0140-6736(10)61156-7, 21296405.
7. Gastl R, Ludolph AC. Amyotrophic lateral sclerosis. Nervenarzt 2007, 78(12):1449-1457. quiz 1458-1459, 10.1007/s00115-007-2354-5, 18038122.
8. Lulé D, Häcker S, Ludolph A, Birbaumer N, Kübler A. Depression and quality of life in patients with amyotrophic lateral sclerosis. Dtsch Arztebl Int 2008, 105(23):397-403. 2696844, 19626161.
9. Ludolph AC. Motor neuron disease: urgently needed-biomarkers for amyotrophic lateral sclerosis. Nat Rev Neurol 2011, 7(1):13-14. 10.1038/nrneurol.2010.196, 21221113.
10. Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, et al. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol 2009, 65(4):378-385. 10.1002/ana.21653, 19399866.
11. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial " Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994, 124(Suppl):96-107.
12. Brooks BR. Versailles minimal dataset for diagnosis of ALS: a distillate of the 2nd Consensus Conference on accelerating the diagnosis of ALS. Versailles 2nd Consensus Conference participants. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1(Suppl 1):S79-S81.
13. Morfeld M, Bullinger M, Nantke J, Brähler E. The version 2.0 of the SF-36 health survey: results of a population-representative study. Soz Praventivmed 2005, 50(5):292-300. 10.1007/s00038-005-4090-6, 16300173.
14. Bernheim JL. How to get serious answers to the serious question: " How have you been?" : subjective quality of life (QOL) as an individual experiential emergent construct. Bioethics 1999, 13(3-4):272-287.
15. Herrmann C, Buss U, und Snaith RP. HADS-D - Hospital Anxiety and Depression Scale - Deutsche Version: Ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin 1995, Bern: Huber.
16. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000, 55(11):1621-1626. 10.1212/WNL.55.11.1621, 11113214.
17. Nasreddine ZS, Phillips N, Chertkow H. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology 2012, 78(10):765-766. author reply 766.
18. Lang JWB, Fries S. A revised 10-item version of the achievement motives scale: psychometric properties in German-speaking samples. Eur J Psychol Assess 2006, 22:216-224.
19. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1(5):293-299. 10.1080/146608200300079536, 11464847.
20. The ALS registry Swabia 2012, The ALS registry Swabia., http://www.als-register.net
21. Beghi E, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta 2006, 1762(11-12):1150-1157.
22. The European ALS Consortium (EURALS)-exercise study 2012, The European ALS Consortium (EURALS)-exercise study., http://www.mnd.ie/current-research/eurals-exercise-study
23. Arts DGT, De Keizer NF, Scheffer G-J. Defining and improving data quality in medical registries: a literature review, case study, and generic framework. J Am Med Inform Assoc 2002, 9(6):600-611. 10.1197/jamia.M1087, 349377, 12386111.
24. State of Baden-Württemberg statistical office 2012, State of Baden-Württemberg statistical office., http://www.statistik.baden-wuerttemberg.de/BevoelkGebiet/
25. Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatr 2010, 81(4):385-390. 10.1136/jnnp.2009.183525, 2850819, 19710046.
26. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology 2008, Philadelphia: Lippincott Williams and Wilkins, Third.
27. Nagel G, Rosenbohm A, Ünal H, Rothenbacher D, Ludolph A. für die ALS-Register-Studiengruppe. Möglichkeiten register-basierter Studien zur Erforschung seltener Erkrankungen. Aktuelle Neurologie 2012, 39(01):12-17.
28. Heemstra HE, Van Weely S, Büller HA, Leufkens HGM, De Vrueh RLA. Translation of rare disease research into orphan drug development: disease matters. Drug Discov Today 2009, 14(23-24):1166-1173.
29. Rubinstein YR, Groft SC, Bartek R, Brown K, Christensen RA, Collier E, et al. Creating a global rare disease patient registry linked to a rare diseases biorepository database: rare disease-HUB (RD-HUB). Contemp Clin Trials 2010, 31(5):394-404. 10.1016/j.cct.2010.06.007, 2930109, 20609392.
30. Forrest CB, Bartek RJ, Rubinstein Y, Groft SC. The case for a global rare-diseases registry. Lancet 2011, 377(9771):1057-1059. 10.1016/S0140-6736(10)60680-0, 20674966.